← FDA Drug Approvals (Drugs@FDA)

APREMILAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2024-12-16

Drug application

FDA Application #

ANDA211887

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREMILAST

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

First approval

2024-12-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown